Leptin constrains phospholipase C-protein kinase C-induced insulin secretion via a phosphatidylinositol 3-kinase-dependent pathway

Experimental Biology and Medicine

Volumn 228, Issue 2, 2003, Pages 175-182

  Lee, Joo Won ^a   Swick, Andrew G ^b   Romsos, Dale R ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Insulin secretion; Lepob Lepob mice; Leptin; Phosphatidylinositol 3 kinase; Phospholipase C protein kinase C

Indexed keywords

LEPTIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE C; PROTEIN KINASE C;

ACETYLCHOLINE RELEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASAL METABOLIC RATE; CONTROLLED STUDY; GENE DISRUPTION; GENE MUTATION; HORMONAL REGULATION; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN RESPONSE; MOUSE; NEUROTRANSMITTER RELEASE; NONHUMAN; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0037315210     PISSN: 15353702     EISSN: None     Source Type: Journal    
DOI: 10.1177/153537020322800207     Document Type: Article

References (39)

1. Zhang Y, Proenca R, Maffei M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 372:425-431, 1994.
2. Lin P-Y, Romsos DR, Leveille GA. Food intake, body weight gain, and body composition of the young obese (ob/ob) mouse. J Nutr 107:1715-1723, 1977.
3. Boissonneault GA, Hornshuh MJ, Simons JW, Romsos DR, Leveille GA. Oxygen consumption and body fat content of young lean and obese (ob/ob) mice. Proc Soc Exp Biol Med 157:402-406, 1978.
4. Trayhurn P, Thurlby P, James WPT. Thermogenic defect in pre-obese ob/ob mice. Nature 266:60-62, 1977.
5. Dubuc PU. The development of obesity, hyperinsulinemia, and hyperglycemia in ob/ob mice. Metabolism 25:1567-1574, 1976.
6. Kulkarni RN, Wang Z-L, Wang R-M, Hurley JD, Smith DM, Ghatei MA, Withers DJ, Gardiner JV, Bailey CJ, Bloom SR. Leptin rapidly suppresses insulin release from insulinoma cells, rat and human islets and, in vivo, in mice. J Clin Invest 100:2729-2736, 1997.
7. Seufert J, Kieffer TJ, Habener JF. Leptin inhibits insulin gene transcription and reverses hyperinsulinemia in leptin-deficient ob/ob mice. Proc Natl Acad Sci USA 96:674-679, 1999.
8. Kieffer TJ, Habener JF. The adipoinsular axis: Effects of leptin on pancreatic cells. Am J Physiol 278:E1-E14, 2000.
9. 2+, cAMP and diacylglycerol. Mol Cell Endocrinol 70:119-137, 1990.
10. Lee J-W, Romsos DR. Leptin-deficient mice commence hypersecreting insulin in response to acetylcholine between 1 and 2 weeks of age. Exp Biol Med 226:906-911, 2001.
11. Chen N-G, Romsos DR. Enhanced sensitivity of pancreatic islets from preobese 2 week old ob/ob mice to neurohormonal stimulation of insulin secretion. Endocrinology 136:505-511, 1995.
12. 2+, cAMP, and phospholipid-derived messengers in coupling mechanisms of insulin secretion. Physiol Rev 67:1185-1248, 1987.
13. Zawalich WS, Zawalich KC, Rasmussen H. Interaction between cholinergic agonists and enteric factors in the regulation of insulin. Acta Endocrinol 120:702-707, 1989.
14. Chen N-G, Swick AG, Romsos DR. Leptin constrains acetylcholine-induced insulin secretion from pancreatic islets of ob/ob mice. J Clin Invest 100:1174-1179, 1997.
15. Ookuma M, Ookuma K, York DA. Effects of leptin on insulin secretion from isolated rat pancreatic islets. Diabetes 47:219-223, 1998.
16. Zhao AZ, Bornfeldt KE, Beavo JA. Leptin inhibits insulin secretion by activation of phosphodiesterase 3B. J Clin Invest 102:869-873, 1998.
17. Garrel G, McArdle CA, Hemmings BA, Counis R. Gonadotropin-releasing hormone and pituitary adenylate cyclase-activating polypeptide affect levels of cyclic adenosine 3′,5′ -monophosphate-dependent protein kinase A (PKA) subunits in the clonal gonadotrope αT3-1 cells: Evidence for cross-talk between PKA and protein kinase C pathways. Endocrinology 138:2259-2266, 1997.
18. + channels in the rat insulinoma cell line CRI-G1. J Physiol 510:47-61, 1998.
19. ATP channel activation in the rat CRI-G1 insulinoma cell line. J Biol Chem 275:4660-4669, 2000.
20. 12 myotubes: Evidence for a PI 3-kinase mediated effect. Diabetologia 40:606-609, 1997.
21. 12 myotubes via janus kinase-2 (JAK-2) and insulin receptor substrate-2 (IRS-2) dependent pathways. Diabetologia 40:1358-1362, 1997.
22. Yano H, Nakanishi S, Kimura K, Hanai N, Saitoh Y, Fukui Y, Nonomura Y, Matsuda Y. Inhibition of histamine secretion by wortmannin through the blockade of phosphatidylinositol 3-kinase in RBL-2H3 cells. J Biol Chem 268:25846-25856, 1993.
23. Lacy PE, Kostianovsky M. Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 16:35-39, 1967.
24. Kekow J, Ulrichs K, Muller-Ruchholtz W, Gross WL. Measurement of rat insulin ELISA with increased sensitivity, high accuracy and greater practicability than established radioimmunoassay. Diabetes 37:321-326, 1988.
25. Drucker DJ, Philippe J, Mojsov S, Chick WL, Habener JF. Glucagon-like peptide-1 stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line. Proc Natl Acad Sci USA 84:3434-3438, 1987.
26. Göke R, Conlon JM. Characterization of the receptor for glucagon-like peptide-1 (7-36) amide on rat insulinoma-derived cells. J Endocrinol 116:357-362, 1988.
27. Seamon KB, Daly JW. Activation of adenylate cyclase by the diterpene forskolin does not require the guanine nucleotide regulatory protein. J Biol Chem 256:9799-9801, 1981.
28. Beavo JA, Rogers NL, Crofford OB, Hardman JG, Sutherland EW, Newman EV. Effect of xanthine derivatives on lipolysis and on adenosine-3′,5′-monophosphate phosphodiesterase activity. Mol Pharmacol 6:597-603, 1970.
29. Harrison SA, Reifsnyder DH, Gallis B, Cadd GG, Beavo JA. Isolation and characterization of bovine cardiac muscle cGMP-inhibited phosphodiesterase: A receptor for new cardiotonic drugs. Mol Pharmacol 29:506-514, 1986.
30. Chen N-G, Romsos DR. Persistently enhanced sensitivity of pancreatic islets from ob/ob mice to PKC-stimulated insulin secretion. Am J Physiol 272:E304-E311, 1997.
31. 2+] elevation signals. Diabetes 51:87-97, 2002.
32. Zawalich WS, Zawalich KC. A link between insulin resistance and hyperinsulinemia: Inhibitors of phosphatidylinositol 3-kinase augment glucose-induced insulin secretion from islets of lean, but not obese, rats. Endocrinology 141:3287-3295, 2000.
33. Ma YH, Wang J, Rodd GG, Bolaffi JL, Grodsky GM. Differences in insulin secretion between the rat and mouse: Role of cAMP. Eurp J Endocrinol 132:370-376, 1995.
34. Zawalich WS. Regulation of insulin secretion by phosphoinositide-specific phospholipase C-protein kinase C activation. Diabetes Rev 4:160-176, 1996.
35. Black M, Heick HM, Bégin-Heick N. Abnormal regulation of insulin secretion in genetically obese (ob/ob) mouse. Biochem J 238:863-869, 1986.
36. Cases JA, Gabriely I, Ma XH, Yang XM, Michaeli T, Fleischer N, Rossetti L, Barzilai N. Physiological increase in plasma leptin markedly inhibits insulin secretion in vivo. Diabetes 50:348352, 2001.
37. Poitout V, Rouault C, Guerre-Millo M, Briaud I, Reach G. Inhibition of insulin secretion by leptin in normal rodent islets of Langerhans. Endocrinology 139:822-826, 1998.
38. Gao Z-Y, Konrad RJ, Collins H, Matschinsky FM, Rothenberg PL, Wolf BA. Wortmannin inhibits insulin secretion in pancreatic islets and β-TC3 cells independent of its inhibition of phosphatidylinositol 3-kinase. Diabetes 45:854-862, 1996.
39. Attoub S, Noe V, Pirola L, Bruyneel E, Chastre E, Mareel M, Wymann MP, Gespach C. Leptin promotes invasiveness of kidney and colonic epithelial cells via phophoinositide 3-kinase-, rho-, and rac-dependent signaling pathways, FASEB J 14:2329-2338, 2000.